Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07087249 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility and Preliminary Effects of a Therapeutic Approach Using Ultrasound Visual Biofeedback in Children With AFI: a Pilot Randomized Clinical Trial.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 1 month later Sep 1, 2025 → Oct 1, 2027
See other at-risk trials from Aline Mara de Oliveira

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 1, 2025 to Oct 1, 2027 Show 8 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Aug 6, 2025 to Apr 1, 2026
    • Study completion pushed from Jan 15, 2026 to Jan 20, 2028
    • Eligibility criteria shortened, about 7 words
    • Study description shortened, about 1,042 words
    • Site details revised
    • Publications: details revised at 2 of 2 entries
    • Study title expanded, about 11 words
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to evaluate the feasibility of the Ultrax protocol and estimate preliminary effects on articulatory precision, prosody, and speech motor planning. This is a pilot randomized clinical trial employing both quantitative and qualitative approaches. Participants will be children aged five to twelve years diagnosed with Childhood Apraxia of Speech. The intervention will be conducted over six weeks, with two sessions per week. Following an initial assessment, participants will be randomized into either an intervention group or a waitlist control group. Assessments will be performed pre- and post-intervention, as well as at a one-month follow-up. Data analysis will be exploratory, focusing on evaluating the feasibility of the procedures and estimating parameters for future studies. Primary outcomes will include feasibility indicators such as recruitment rate, adherence, treatment fidelity, acceptability, and retention. Secondary outcomes will involve the analysis of preliminary speech performance measures and effect size estimation. The results are expected to provide preliminary effect estimates and inform the design of a definitive randomized clinical trial.
Trial Details
NCT Number NCT07087249
Lead Sponsor Aline Mara de Oliveira
Conditions
(from sponsor)
Childhood Apraxia of Speech, Speech Sound Disorders
Related terms Apraxias, Communication Disorders, Speech Sound Disorder
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov